CCL5 and glioblastoma: Moreover, it has recently been reported both CXCL10 and C-C motif chemokine ligand 5 (CCL5) are abundantly secreted by glioblastoma (GBM) cells upon exposure to the lysosomal inhibitor chloroquine, resulting in accrued accumulation of adoptively transferred CAR-expressing NK cells in support of superior therapeutic activity [53].